Vital signs: Central line-associated blood stream infections - United States, 2001, 2008, and 2009

Morbidity and Mortality Weekly Report

Volumn 60, Issue 8, 2011, Pages 243-248

  Srinivasan, A ^a   Wise, M ^a   Bel, M ^a   Cardo, D ^a   Edwards, J ^a   Fridkin, S ^a   Jernigan, J ^a   Kallen, A ^a   Mcdonald, Lc ^a   Patel, Pr ^a   Pollock, D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CHILD; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; OUTPATIENT; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFECTION CONTROL; INPATIENTS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OUTPATIENTS; RENAL DIALYSIS; UNITED STATES;

EID: 79952643764     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Centers for Medicare & Medicaid Services. Hospital-acquired conditions. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2010. Available at https://www.cms.gov/hospitalacqcond/06_hospital-acquired_conditions.asp Accessed February 3, 2011.
2. CDC. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51(No. RR-10).
3. CDC. Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR 2005;54:1013-6.
4. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-32.
5. US Department of Health and Human Services. National action plan to reduce healthcare-associated infections. Washington, DC: US Department of Health and Human Services; 2010. Available at http://www.hhs.gov/ash/initiatives/hai/actionplan/index.html Accessed February 3, 2011.
6. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002;5:143-51.
7. Centers for Medicare & Medicaid Services. Hospital cost report. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2010. Available at http://www.cms.gov/costreports/02_hospitalcostreport.asp#topofpage. Accessed February 3, 2011.
8. American Hospital Association. Survey history & methodology. Chicago, IL: American Hospital Association. Available at http://www.ahadata.com/ahadata/html/historymethodology.html. Accessed February 3, 2011.
9. CDC. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004. Am J Infect Control 2004;32:470-85.
10. CDC. NHSN newsletter: revised LCBI definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at http://www.cdc.gov/nhsn/pdfs/newsletters/january2008.pdf Accessed February 3, 2011.
11. US Renal Data System. Annual data report. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2010. Available at http://www.usrds.org/adr.htm. Accessed February 3, 2011.
12. Fistula First Breakthrough Initiative. Fistula First data: prevalent counts and rates. Lake Success, NY: Fistula First Breakthrough Initiative; 2009. Available at http://www.fistulafirst.org/aboutfistulafirst/ffbidata.aspx Accessed February 3, 2011.
13. Rothman K, Boice J. Epidemiologic analysis with a programmable calculator. 2nd ed. Boston, MA: Epidemiology Resources; 1982.
14. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301:727-36.
15. Hu KK, Veenstra DL, Lipsky BA, Saint S. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 2004;39:1441-5.
16. CDC. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009;58:256-60.
17. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10 Suppl 2):S165-93.
18. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-106.
19. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008;23:3219-26.
20. Allon M. Fistula First: recent progress and ongoing challenges. Am J Kidney Dis 2011;57:3-6.
21. Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients. Am J Kidney Dis 2010;56:566-77.
22. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148:596-605.
23. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160-6.
24. Pronovost PJ, Cardo DM, Goeschel CA, Berenholtz SM, Saint S, Jernigan JA. A research framework for reducing preventable patient harm. Clin Infect Dis 2011 (in press).